Prescription drug · BLA
Vyvgart (Efgartigimod alfa) NDC 73475-3041
Efgartigimod alfa 20 mg/mL · Injection · Intravenous · argenx US
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73475-3041-5 | 73475304105 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3041-5) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 17, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vyvgart
- Generic name (nonproprietary)
- efgartigimod alfa
- Active ingredients
- Efgartigimod alfa — 20 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- argenx USNDC labeler code 73475
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761195
- Marketing start
- Listing expires
- Other FDA classes
- Neonatal Fc Receptor Blockers (Mechanism)
- Identifiers
- Product ID 73475-3041_3bce287a-2242-4c56-ba66-c06cc0eec56cSPL ID 3bce287a-2242-4c56-ba66-c06cc0eec56cSPL set ID 8aefc8e3-26d6-4ff6-aab9-a7542927e084RxCUI 2587723, 2587729UNII 961YV2O515
- Pharmacologic class
- Neonatal Fc Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N473475304105followed by a unit qualifier and the quantityPackage 73475-3041-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
VYVGART is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). VYVGART is a neonatal Fc receptor blocker indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 73475-3041
- What is NDC 73475-3041?
- 73475-3041 is the product NDC for Vyvgart (efgartigimod alfa), Efgartigimod alfa 20 mg/mL injection, listed with the FDA by argenx US. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Vyvgart (Efgartigimod alfa).
- What is the active ingredient?
- Efgartigimod alfa.
- Who is the labeler?
- argenx US, NDC labeler code 73475. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Vyvgart?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.